Recent reports of the Congressional Research Service on topics related to openness and transparency include the following (all pdf).
“Does Price Transparency Improve Market Efficiency? Implications of Empirical Evidence in Other Markets for the Health Sector,” July 24, 2007.
“State E-Government Strategies: Identifying Best Practices and Applications,” July 23, 2007.
“Clinical Trials Reporting and Publication,” updated July 12, 2007.
“Freedom of Information Act Amendments: 110th Congress,” updated July 10, 2007.
FAS commends the Senate Committee on Energy and Natural Resources for clearing a historic 75 pieces of legislation, including multiple crucial bills to confront the wildfire crisis.
The United States needs a strategic investment fund (SIF) to shepherd promising technologies in nationally vital sectors through the valley of death.
Standardizing support for Accessibility & Accommodations in federally funded research efforts would open opportunities for disabled scientists and their research programs.
The incoming administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases.